| CTMX Snapshot | |
|---|---|
| CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States. The company is headquartered in South San Francisco, California. | |
| VALUATION DATA | |
| Market Capitalization | $117,176,000 | Price to Sales | 5.00 |
| Earnings per Share | $-0.0100 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $1.7300 |
| 52 Week High | $1.439 |
| 52 Week Low | $5.04 |
| 50-Day Moving Average | $0.0156 |
| 200-Day Moving Average | $3.461 |
| All data are from Alpha Vantage as of today. For more infomation on CTMX see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search